| A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration (NCT04640272) | Ribomic USA Inc | 2020-11-03 |
| A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration (NCT04200248) | Ribomic USA Inc | 2019-12-02 |
| Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD (NCT05539235) | First Affiliated Hospital of Chongqing Medical University | 2018-11-12 |
| Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF (NCT03071055) | Southeast Clinical Research Associates, LLC | 2017-10-01 |
| Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy (NCT02976194) | Pusan National University Hospital | 2016-11-22 |
| Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD (NCT02732899) | Maturi, Raj K., M.D., P.C. | 2016-04-01 |
| Intravitreal Aflibercept for Submacular Hemorrhage (NCT03169660) | Kim's Eye Hospital | 2015-12-01 |
| Stem Cell Therapy for Outer Retinal Degenerations (NCT02903576) | Federal University of São Paulo | 2015-08-01 |
| X-82 to Treat Age-related Macular Degeneration (NCT02348359) | Tyrogenex | 2015-03-16 |
| LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration (NCT02355028) | Alcon, a Novartis Company | 2015-03-03 |
| Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD (NCT03744806) | Medical University of Lublin | 2015-01-01 |
| Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration (NCT02328209) | Mie University | 2014-06-01 |
| Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept (NCT02125864) | Oslo University Hospital | 2014-04-01 |
| Monocentric Retrospective Observational Study on Patients With Macular Degeneration (NCT02089503) | Hospital St. Joseph, Marseille, France | 2014-03-01 |
| Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 (NCT01961414) | Palmetto Retina Center, LLC | 2013-10-01 |
| Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy (NCT01950741) | Pusan National University Hospital | 2013-09-01 |
| ESBA1008 Microvolume Study (NCT01849692) | Alcon Research | 2013-06-01 |
| Efficacy and Safety Study of ESBA1008 Versus EYLEA® (NCT01796964) | Alcon Research | 2013-03-01 |
| Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (NCT01414153) | Lpath, Inc. | 2012-08-01 |
| Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration (NCT01526070) | Stanford University | 2012-01-01 |
| Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD) (NCT01527435) | The Retina Center of St. Louis County, PC | 2011-12-01 |
| Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation (NCT01404845) | Affordance | 2011-09-01 |
| Long-term Follow-up of Subfoveal Neovascular AMD (NCT01608113) | Medical University of Vienna | 2011-09-01 |
| Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration (NCT01157065) | Alcon Research | 2011-06-01 |
| Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD (NCT01819415) | Maisonneuve-Rosemont Hospital | 2011-02-01 |
| Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab (NCT01810042) | Pusan National University Hospital | 2010-10-01 |
| ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients (NCT01304693) | Alcon Research | 2010-10-01 |
| ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) (NCT01213082) | University of California, Davis | 2010-09-01 |
| Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion (NCT00913744) | ThromboGenics | 2010-01-01 |
| The Spectralis-Cirrus Study (NCT00927303) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2009-07-01 |
| LUCAS (Lucentis Compared to Avastin Study) (NCT01127360) | Oslo University Hospital | 2009-03-01 |
| A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD (NCT00793923) | Subhransu K. Ray, M.D., Ph.D. | 2008-01-01 |